BDBM50337910 (+/-)-1-(1-(3,4-dichlorophenyl)cyclohexyl)-N-methylethanamine::1-(1-(3,4-dichlorophenyl)cyclohexyl)-N-methylethanamine::CHEMBL1684045::CHEMBL1684057::US10562878, Compound 108

SMILES CNC(C)C1(CCCCC1)c1ccc(Cl)c(Cl)c1

InChI Key InChIKey=ZJNJPYFFMXVAGY-UHFFFAOYSA-N

Data  42 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 42 hits for monomerid = 50337910   

TargetSodium-dependent dopamine transporter(Human)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 297nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetNeuroepithelial cell-transforming 1(Rat)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 2.20nMAssay Description:Quantification of norepinephrine uptake was performed using synaptosomes isolated in a 0.32 M sucrose buffer from a male Wistar rat hypothalamus. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Rat)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 150nMAssay Description:Quantification of dopamine uptake was performed using synaptosomes isolated in a 0.32 M sucrose buffer from a male Wistar rat striatum. The uptake of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 239nMAssay Description:Inhibition of human serotonin reuptake transporter was assayed using the recombinant human serotonin transporter expressed in HEK-293 cells. HEK-293 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetNeuroepithelial cell-transforming gene 1 protein(Human)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 570nMAssay Description:Inhibition of human norepinephrine reuptake transporter was assayed using the recombinant human norepinephrine transporter expressed in either HEK293...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Human)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 219nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Rat)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 210nMAssay Description:Quantification of 5-HT uptake was performed using synaptosomes isolated in a 0.32M sucrose buffer from a male Wistar rat cortex. The uptake of radiol...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetNeuroepithelial cell-transforming 1(Rat)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 44nMAssay Description:Quantification of norepinephrine uptake was performed using synaptosomes isolated in a 0.32 M sucrose buffer from a male Wistar rat hypothalamus. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Rat)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 1.80E+3nMAssay Description:Quantification of dopamine uptake was performed using synaptosomes isolated in a 0.32 M sucrose buffer from a male Wistar rat striatum. The uptake of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 149nMAssay Description:Inhibition of human serotonin reuptake transporter was assayed using the recombinant human serotonin transporter expressed in HEK-293 cells. HEK-293 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetNeuroepithelial cell-transforming gene 1 protein(Human)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 441nMAssay Description:Inhibition of human norepinephrine reuptake transporter was assayed using the recombinant human norepinephrine transporter expressed in either HEK293...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Rat)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 14nMAssay Description:Quantification of 5-HT uptake was performed using synaptosomes isolated in a 0.32M sucrose buffer from a male Wistar rat cortex. The uptake of radiol...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Rat)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 230nMAssay Description:Quantification of 5-HT uptake was performed using synaptosomes isolated in a 0.32M sucrose buffer from a male Wistar rat cortex. The uptake of radiol...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetNeuroepithelial cell-transforming 1(Rat)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 74nMAssay Description:Quantification of norepinephrine uptake was performed using synaptosomes isolated in a 0.32 M sucrose buffer from a male Wistar rat hypothalamus. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Rat)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 550nMAssay Description:Quantification of dopamine uptake was performed using synaptosomes isolated in a 0.32 M sucrose buffer from a male Wistar rat striatum. The uptake of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 81nMAssay Description:Inhibition of human serotonin reuptake transporter was assayed using the recombinant human serotonin transporter expressed in HEK-293 cells. HEK-293 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetNeuroepithelial cell-transforming gene 1 protein(Human)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 57nMAssay Description:Inhibition of human norepinephrine reuptake transporter was assayed using the recombinant human norepinephrine transporter expressed in either HEK293...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Human)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 30nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Rat)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 54nMAssay Description:Quantification of 5-HT uptake was performed using synaptosomes isolated in a 0.32M sucrose buffer from a male Wistar rat cortex. The uptake of radiol...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetNeuroepithelial cell-transforming 1(Rat)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 5.10nMAssay Description:Quantification of norepinephrine uptake was performed using synaptosomes isolated in a 0.32 M sucrose buffer from a male Wistar rat hypothalamus. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Rat)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 170nMAssay Description:Quantification of dopamine uptake was performed using synaptosomes isolated in a 0.32 M sucrose buffer from a male Wistar rat striatum. The uptake of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetCytochrome P450 2C9(Human)
Sunovion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2011
Entry Details Article
PubMed
TargetSodium-dependent serotonin transporter(Human)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 150nMAssay Description:Inhibition of [3H]serotonin reuptake at human recombinant SERT expressed in LLC-PK1 cells by liquid scintillation countingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2011
Entry Details Article
PubMed
TargetSodium-dependent noradrenaline transporter(Human)
Sunovion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 37nMAssay Description:Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation countingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2011
Entry Details Article
PubMed
TargetSodium-dependent serotonin transporter(Human)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 65nMAssay Description:Inhibition of [3H]serotonin reuptake at human recombinant SERT expressed in LLC-PK1 cells by liquid scintillation countingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2011
Entry Details Article
PubMed
TargetSodium-dependent noradrenaline transporter(Human)
Sunovion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 37nMAssay Description:Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation countingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2011
Entry Details Article
PubMed
TargetSodium-dependent noradrenaline transporter(Human)
Sunovion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 440nMAssay Description:Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation countingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2011
Entry Details Article
PubMed
TargetSodium-dependent dopamine transporter(Human)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 86nMAssay Description:Inhibition of [3H]dopamine reuptake at human recombinant DAT expressed in COS-7 cells by scintillation countingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2011
Entry Details Article
PubMed
TargetSodium-dependent dopamine transporter(Human)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 86nMAssay Description:Inhibition of [3H]dopamine reuptake at human recombinant DAT expressed in COS-7 cells by scintillation countingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2011
Entry Details Article
PubMed
TargetSodium-dependent dopamine transporter(Human)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 300nMAssay Description:Inhibition of [3H]dopamine reuptake at human recombinant DAT expressed in COS-7 cells by scintillation countingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Sunovion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 2.30E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2011
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Sunovion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2011
Entry Details Article
PubMed
TargetSodium-dependent serotonin transporter(Human)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 65nMAssay Description:Inhibition of [3H]serotonin reuptake at human recombinant SERT expressed in LLC-PK1 cells by liquid scintillation countingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2011
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Sunovion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of CYP3A4More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2011
Entry Details Article
PubMed
TargetCytochrome P450 2D6(Human)
Sunovion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 8.50E+3nMAssay Description:Inhibition of CYP2D6More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Sunovion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 2.30E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2011
Entry Details Article
PubMed
TargetSodium-dependent serotonin transporter(Human)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 65nMAssay Description:Inhibition of human serotonin reuptake transporter was assayed using the recombinant human serotonin transporter expressed in HEK-293 cells. HEK-293 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetNeuroepithelial cell-transforming gene 1 protein(Human)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 36nMAssay Description:Inhibition of human norepinephrine reuptake transporter was assayed using the recombinant human norepinephrine transporter expressed in either HEK293...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Human)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 85nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 12nMAssay Description:Inhibition of human serotonin reuptake transporter was assayed using the recombinant human serotonin transporter expressed in HEK-293 cells. HEK-293 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetNeuroepithelial cell-transforming gene 1 protein(Human)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 10nMAssay Description:Inhibition of human norepinephrine reuptake transporter was assayed using the recombinant human norepinephrine transporter expressed in either HEK293...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Human)
Sunovion Pharamceuticals

US Patent
LigandPNGBDBM50337910(CHEMBL1684057 | 1-(1-(3,4-dichlorophenyl)cyclohexy...)
Affinity DataIC50: 36nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent